Evidence map›Paper›PMID 42730634›Full record

ArticleHuman vaccines & immunotherapeutics2026

Measles as tracer and tugboat: Why eradication can strengthen immunization systems.

David N Durrheim, Jon K Andrus, Mimi Mynak, David Githanga, Mira Kojouharova, Nadia Teleb

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David N DurrheimSchool of Medicine and Public Health, The University of Newcastle - Callaghan Campus, Newcastle, Australia.ORCID 0000-0001-9236-4861
Jon K AndrusMilken Institute School of Public Health, The George Washington University, Washington, DC, USA.
Mimi MynakPaediatrics, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan.
David GithangaPaediatrics, Kenya Paediatric Association, Nairobi, Kenya.
Mira KojouharovaEpidemiology and Communicable Disease Surveillance, Nacionalen cent'r po zarazni i parazitni bolesti, Sofia, Bulgaria.
Nadia TelebVaccine Preventable Diseases and Immunization, World Health Organization Country Egypt, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As measles resurges globally, we face an important strategic choice. Large outbreaks reflect declining vaccination coverage, inequities in health services access, conflict, population displacement, vaccine hesitancy, and inadequate investment in immunization programs. However, measles is more than a vaccine-preventable disease. Because of its extraordinary transmissibility, it functions both as a tracer of weaknesses in immunization systems and public health infrastructure, and as a potential tugboat for strengthening them.The Immunization Agenda 2030 highlights strong immunization systems, equitable service delivery, and effective surveillance as foundations for controlling vaccine-preventable diseases. Bill Foege, a leader of smallpox eradication, argued that measles eradication could reduce health inequalities while acting as a "tugboat" that pulls stronger immunization systems into place. This perspective is increasingly relevant. The capacities required for measles eradication, including high routine immunization coverage, sensitive surveillance, quality laboratory networks, rapid outbreak response, community engagement, and political accountability, are also fundamental to resilient health systems and preparedness for future pandemics.Rather than competing with health-system strengthening, measles eradication can accelerate it. The current resurgence should be viewed not only as a warning signal of system fragility but also as an opportunity to strengthen immunization systems, advance health equity, and renew commitment to global eradication.

Indexed as

Disease EradicationImmunization ProgramsMeaslesDisease OutbreaksGlobal HealthHumansMeasles VaccinePublic Health InfrastructureVaccination CoverageVaccine-Preventable DiseasesMeasles Vaccineepidemic preparednesshealth equityIA2030immunization systemsmeasles eliminationMeasles eradicationroutine immunizationsurveillancevaccination

Identifiers

PMID42730634
PMCPMC13577244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.